We are live on
!
Find out more
PCM
Parsons Capital Management Portfolio holdings
AUM
$2.21B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
+1.25%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+395.61%
AUM
$583M
AUM Growth
–
Cap. Flow
+$588M
Cap. Flow
% of AUM
100.99%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
327
New
327
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$44.9M |
| 2 |
Apple
AAPL
|
+$24.7M |
| 3 |
ExxonMobil
XOM
|
+$18.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$12.9M |
| 5 |
IBM
IBM
|
+$9.87M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.39% |
| 2 | Healthcare | 12.66% |
| 3 | Technology | 11.86% |
| 4 | Energy | 11.67% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
MiMedx Group
MDXG
$602M
| $4.94M | 0.85% |
+699,499
| New | +$4.89M |
|
27
PepsiCo
PEP
$190B
| $4.87M | 0.84% |
+59,526
| New | +$4.86M |
|
28
McDonald's
MCD
$192B
| $4.85M | 0.83% |
+49,003
| New | +$4.91M |
|
29
Pfizer
PFE
$143B
| $4.63M | 0.79% |
+174,224
| New | +$4.81M |
|
30
Merck
MRK
$322B
| $4.6M | 0.79% |
+103,866
| New | +$4.64M |
|
31
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $4.29M | 0.74% |
+97,065
| New | +$4.54M |
|
32
RTX Corp
RTX
$290B
| $4.26M | 0.73% |
+72,873
| New | +$4.31M |
|
33
AbbVie
ABBV
$443B
| $4.15M | 0.71% |
+100,456
| New | +$4.39M |
|
34
SLB Ltd
SLB
$73.6B
| $4.08M | 0.7% |
+56,990
| New | +$4.22M |
|
35
Freeport-McMoran
FCX
$90B
| $3.98M | 0.68% |
+144,236
| New | +$4.4M |
|
36
Verizon
VZ
$195B
| $3.92M | 0.67% |
+77,771
| New | +$3.97M |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $3.91M | 0.67% |
+66,800
| New | +$4.02M |
|
38
Home Depot
HD
$331B
| $3.75M | 0.64% |
+48,447
| New | +$3.64M |
|
|
DNKN
39
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $3.65M | 0.63% |
+85,360
| New | +$3.44M |
|
40
Thermo Fisher Scientific
TMO
$213B
| $3.62M | 0.62% |
+42,815
| New | +$3.56M |
|
41
Oracle
ORCL
$374B
| $3.62M | 0.62% |
+117,838
| New | +$3.91M |
|
42
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $3.58M | 0.61% |
+92,880
| New | +$3.85M |
|
43
Cisco
CSCO
$457B
| $3.56M | 0.61% |
+146,418
| New | +$3.29M |
|
|
AMJ
44
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $3.55M | 0.61% |
+76,035
| New | +$3.52M |
|
45
Blackrock
BLK
$169B
| $3.53M | 0.61% |
+13,748
| New | +$3.68M |
|
46
Caterpillar
CAT
$375B
| $3.5M | 0.6% |
+42,489
| New | +$3.61M |
|
47
Abbott
ABT
$183B
| $3.3M | 0.57% |
+94,621
| New | +$3.47M |
|
48
NOV
NOV
$6.93B
| $3.29M | 0.56% |
+52,900
| New | +$3.26M |
|
49
Bristol-Myers Squibb
BMY
$133B
| $3.26M | 0.56% |
+72,889
| New | +$3.16M |
|
50
General Mills
GIS
$19.1B
| $3.26M | 0.56% |
+67,164
| New | +$3.3M |
|
Similar funds
WCMNY
NLGIA
ML
IFA
DPCM
RAM
GC
ORCP
Parsons Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Parsons Capital Management, which disclosed 327 positions worth $583M. Its ten largest holdings account for 26% of the portfolio.
Its largest position is 3M: 494,144 shares worth $45.2M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, followed by Healthcare and Technology.
- Parsons Capital Management's largest Q2 2013 buy was 3M: 494,144 shares worth $45.2M.
- Parsons Capital Management's ten largest holdings make up 26% of its $583M portfolio in Q2 2013.
- Parsons Capital Management disclosed 327 positions in Q2 2013, its first 13F filing on record.
Based on Parsons Capital Management's 13F filing for Q2 2013, filed 7 Aug 2013.